2021-01-05,Kaleido Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-04,Kaleido Biosciences Announces Completion of Enrollment of 350 Subjects in Controlled Study of KB109 in the Treatment of Mild-to-Moderate COVID-19
2020-12-23,"Benzinga's Top Upgrades, Downgrades For December 23, 2020"
2020-11-24,Kaleido Biosciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-13,New Strong Sell Stocks for November 13th
2020-11-02,Kaleido Biosciences Reports Third Quarter 2020 Financial Results  and Provides Corporate Update
2020-10-23,"Analysts Have Just Cut Their Kaleido Biosciences, Inc. (NASDAQ:KLDO) Revenue Estimates By 20%"
2020-10-07,Kaleido Biosciences Announces Data from MMT Programs Accepted for Presentation at Upcoming Scientific Conferences
2020-10-06,Kaleido Biosciences Provides Update on KB109 Clinical Data Timeline
2020-10-02,Kaleido's Unscreen is dead simple drag-and-drop background removal for video
2020-10-01,Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer
2020-09-29,Kaleido Biosciences Announces First Patient Dosed in Clinical Study of Microbiome Metabolic Therapy KB295 in Patients with Mild-to-Moderate Ulcerative Colitis
2020-09-09,Kaleido Biosciences to Present at Upcoming September Investor Conferences
2020-08-27,Kaleido Biosciences Announces Presentation of Data for Microbiome Metabolic Therapy KB174 for Hepatic Encephalopathy at The Digital  International Liver Congress (EASL)
2020-08-06,"How Much Of Kaleido Biosciences, Inc. (NASDAQ:KLDO) Do Insiders Own?"
2020-08-05,Kaleido Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
2020-08-04,Kaleido Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-07-23,Kaleido Biosciences Initiates Controlled Clinical Study with Massachusetts General Hospital of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19
2020-07-07,Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
2020-06-16,Kaleido Biosciences Announces CEO Leadership Transition
2020-06-08,Kaleido Biosciences Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting
2020-06-07,"Theodose Melas-Kyriazi Is The Independent Director of Kaleido Biosciences, Inc. (NASDAQ:KLDO) And Just Spent US$250k On Shares"
2020-06-04,Kaleido Biosciences to Present During the Goldman Sachs 41st Annual Global Healthcare Conference
2020-06-01,Kaleido Biosciences Announces Pricing of Public Offering of Common Stock
2020-06-01,Kaleido Biosciences Announces Proposed Public Offering of Common Stock
2020-05-28,Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
2020-05-27,"Kaleido BioSciences, Inc. (KLDO): Are Hedge Funds Right About This Stock?"
2020-05-14,Kaleido Biosciences Provides Corporate Update and Reports First Quarter 2020 Financial Results
2020-05-14,Kaleido Biosciences Initiates Controlled Clinical Study of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19
2020-05-12,"Kaleido Biosciences to Host Conference Call and Webcast in Conjunction with First Quarter 2020 Financial Results on May 14, 2020"
2020-04-03,"Kaleido Biosciences Appoints Anne Prener, M.D., Ph.D., to its Board of Directors"
2020-03-31,Is Kaleido Biosciences (KLDO) Stock Outpacing Its Medical Peers This Year?
2020-03-02,Kaleido Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
2020-01-09,"Kaleido Biosciences Announces Collaboration with Janssen to Explore the Potential for Microbiome Metabolic Therapies (MMT) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions by Promoting Healthy Function of the Gut Microbiome"
2020-01-06,Kaleido Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-22,"Here is What Hedge Funds Think About Kaleido BioSciences, Inc. (KLDO)"
2019-12-19,Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
2019-12-12,Kaleido Biosciences to Advance KB174 for Hepatic Encephalopathy Based on Positive Top-Line Results from a Clinical Study in Patients with Cirrhosis
2019-11-06,Kaleido Biosciences Appoints William Duke as Chief Financial Officer
2019-11-05,"Kaleido BioSciences, Inc. (KLDO) Is Burning These Hedge Funds"
2019-10-30,Kaleido Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-10-25,World Wide Fund for Nature uses Ethereum-based Kaleido to conjure up Impactio
2019-10-22,Kaleido Biosciences and Washington University School of Medicine to Collaborate on Exploring the Influence of Microbiome Metabolic Therapies (MMT) on Physiology and Metabolism
2019-10-03,Kaleido Biosciences Presents Ex Vivo Data of KB109 Demonstrating Reduction of Multi-drug Resistant Pathogens at IDWeek 2019
2019-09-30,Kaleido Biosciences Announces Appointment of Jean Mixer to its Board of Directors
2019-09-27,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave"
2019-09-26,Kaleido Biosciences Announces CFO Transition
2019-09-09,Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center to Develop Microbiome Metabolic Therapies (MMT) in Immuno-oncology
2019-09-03,Kaleido Biosciences Presents Data from Clinical Study of KB195 in Patients with Urea Cycle Disorders at Society for the Study of Inborn Errors of Metabolism Annual Symposium
2019-08-29,Kaleido Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
2019-08-08,Microbiome biotechs grapple with how to protect their IP
2019-08-01,Kaleido Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-07-31,Kaleido Biosciences to Present at the 39th Annual Canaccord Genuity Growth Conference
2019-07-22,Kaleido Biosciences Appoints Jerald Korn as General Counsel and Corporate Secretary
2019-07-18,"How Many Kaleido BioSciences, Inc. (NASDAQ:KLDO) Shares Did Insiders Buy, In The Last Year?"
2019-07-15,Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors
2019-06-26,Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement  Drug Development Summit
2019-06-03,Kaleido Biosciences to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
2019-05-08,"In slow year for life science IPOs, this venture firm is making big money"
2019-05-02,Kaleido Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update
2019-04-23,"Long-Term ""GameChangers"" in Biotech"
2019-04-12,Kaleido Biosciences Announces Presentation of Clinical Study and Ex Vivo Data Supporting the Development of Novel Microbiome Metabolic Therapies for Hyperammonemia at The International Liver Congress 2019 (EASL)
2019-04-08,Kaleido Biosciences Announces Key Appointments to Leadership Team
2019-03-27,Kaleido Biosciences Announces Upcoming Presentations at the Society for Inherited Metabolic Disorders Annual Meeting and The International Liver Congress (EASL)
2019-03-21,Kaleido Biosciences Announces Initiation of Dosing in Non-IND Clinical Studies in Patients with Urea Cycle Disorders and Cirrhosis
2019-03-08,Kaleido Biosciences to Highlight its Platform to Identify and Evaluate Microbiome Metabolic Therapies to Reduce Gut Ammonia Production in Presentation at Keystone Symposia on Microbiome
2019-03-04,Kaleido Biosciences Announces Closing of Initial Public Offering
2019-02-28,"Nasdaq Welcomes Kaleido Biosciences, Inc. (Nasdaq: KLDO) to the Nasdaq Stock Market"
2019-02-27,Kaleido Biosciences Announces Pricing of Initial Public Offering
2019-02-24,IPO Outlook For The Week: Gaming And Biotech
